Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia

Clinical trial NCT07087847 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07087847
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Leukemia Acute Leukemia Refractory Acute Myeloid Leukemia (AML)ALL (Acute B-Lymphoblastic Leukemia)Acute Leukemia in Relapse

Start date: 2025-09-01
Primary completion: 2028-01-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.